Company: REVB
Filing Date: 2025-11-12
Form Type: S-8
Source: 0001193125-25-277581
Chunk: 3

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: S-8
Chunk 3
---
 contained in the Delaware General Corporation Law. These indemnification agreements generally require us, among other things, to indemnify our officers and directors against certain liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also generally require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended, or the Securities Act. Item 7. Exemption from Registration Claimed Not applicable.

Item 8. Exhibits

| Exhibit Number 
 4.1            |     | Title of Document                                                   
 Common Stock Specimen                                               |     | Location                                                                                                     
 Incorporated by reference to the Registration Statement on Form S-1 filed May 23, 2025                       |
|:---------------|:----|:--------------------------------------------------------------------|:----|:-------------------------------------------------------------------------------------------------------------|
| 5.1            |     | Opinion of Fox Rothschild LLP                                       |     | This filing                                                                                                  |
| 10.1           |     | Revelation Biosciences, Inc. 2021 Equity Incentive Plan, as amended |     | Incorporated by reference to Appendix A to the definitive proxy statement filed with the SEC on June 6, 2025 |
| 23.1           |     | Baker Tilly US, LLP                                                 |     | This filing                                                                                                  |
| 23.2           |     | Consent of Fox Rothschild LLP                                       |     | Included in Exhibit 5.01                                                                                     |
| 24.1           |     | Power of Attorney                                                   |     | See signature page to this filing                                                                            |
| 107            |     | Filing Fee Table                                                    |     | This filing                                                                                                  |

Item 9. Undertakings Undertaking Required by Item 512(a) of Regulation S-K : The undersigned registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| (i) | To include any prospectus required by section 10(a)(3) of the Securities Act; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (